By MICHAEL J. de la MERCED
The drugmaker had built itself into a $124 billion powerhouse in large part through repeated deals, for companies like Forest Laboratories.
Published: July 25, 2015 at 12:00AM
from NYT Business Day. Read more at: http://ift.tt/1IjU6fU